SENS Foundation is a charity* which works to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address the disabilities and diseases of aging.  Rejuvenation biotechnologies encompass the application of regenerative medicine - defined in its widest sense, to include the repair of living cells and extracellular material in situ - to the damage of aging. The Foundation catalyses progress toward a comprehensive panel of rejuvenation biotechnologies through its growing global networks and collaborations, and through key research projects, executed in its own Research Center and numerous affiliated universities, research organizations and other centers of excellence.

Our research is governed by a strategic agenda to demonstrate the feasibility of rejuvenation biotechnologies, as a natural extension of regenerative medicine as applied to aging, and therefore drive broader involvement. We have assembled a world class team of advisors; we  continue to build on the successful biennial Aging (US) and SENS (UK) Conferences; our expanding affiliations include non-profits with complementary missions, research organizations, government support, and technology transfer with mainstream biotechnology companies; our outreach and education activities raise awareness and interest in both the scientific and general communities.

The challenge is not small. We are proposing nothing less than a transformation of medicine; away from the increasingly burdensome and unprofitable chase to treat pathologies, and towards a functional and, for society as a whole, more cost-effective approach to maintaining and extending individual health.

You can read more about our mission and message in this post by co-founder and Executive Vice President, Sarah Marr.

We hope that you will share our vision, and that you will join us on what promises to be a remarkable journey.

* SENS Foundation is a 501(c)(3) public charity.  Donations are fully deductible as a charitable contribution.